Annual EBITDA
-$253.43 M
-$19.62 M-8.39%
December 31, 2023
Summary
- As of February 23, 2025, CVAC annual EBITDA is -$253.43 million, with the most recent change of -$19.62 million (-8.39%) on December 31, 2023.
- During the last 3 years, CVAC annual EBITDA has fallen by -$142.57 million (-128.60%).
- CVAC annual EBITDA is now -219.97% below its all-time high of -$79.20 million, reached on December 31, 2018.
Performance
CVAC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$412.68 M
+$483.70 M+681.03%
September 1, 2024
Summary
- As of February 23, 2025, CVAC quarterly EBITDA is $412.68 million, with the most recent change of +$483.70 million (+681.03%) on September 1, 2024.
- Over the past year, CVAC quarterly EBITDA has stayed the same.
- CVAC quarterly EBITDA is now at all-time high.
Performance
CVAC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$186.66 M
+$458.59 M+168.64%
September 1, 2024
Summary
- As of February 23, 2025, CVAC TTM EBITDA is $186.66 million, with the most recent change of +$458.59 million (+168.64%) on September 1, 2024.
- Over the past year, CVAC TTM EBITDA has stayed the same.
- CVAC TTM EBITDA is now at all-time high.
Performance
CVAC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CVAC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | 0.0% | 0.0% |
| 3 y3 years | -128.6% | 0.0% | 0.0% |
| 5 y5 years | -220.0% | 0.0% | 0.0% |
CVAC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +44.6% | at high | +420.6% | at high | +140.4% |
| 5 y | 5-year | -147.4% | +44.6% | at high | +337.6% | at high | +136.1% |
| alltime | all time | -220.0% | +44.6% | at high | +337.6% | at high | +136.1% |
CureVac NV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $412.68 M(-681.0%) | $186.66 M(-168.6%) |
| Jun 2024 | - | -$71.02 M(+1.1%) | -$271.93 M(+2.1%) |
| Mar 2024 | - | -$70.25 M(-17.1%) | -$266.29 M(+6.3%) |
| Dec 2023 | -$253.43 M(+8.4%) | -$84.74 M(+84.6%) | -$250.40 M(-14.9%) |
| Sep 2023 | - | -$45.91 M(-29.8%) | -$294.40 M(+1.8%) |
| Jun 2023 | - | -$65.39 M(+20.3%) | -$289.20 M(+4.6%) |
| Mar 2023 | - | -$54.36 M(-57.8%) | -$276.43 M(+21.9%) |
| Dec 2022 | -$233.81 M(-48.9%) | -$128.74 M(+216.3%) | -$226.75 M(+131.6%) |
| Sep 2022 | - | -$40.70 M(-22.6%) | -$97.89 M(-55.2%) |
| Jun 2022 | - | -$52.62 M(+1024.6%) | -$218.54 M(-35.6%) |
| Mar 2022 | - | -$4.68 M(-4361.6%) | -$339.56 M(-26.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$457.28 M(+312.5%) | $109.80 K(-100.1%) | -$462.20 M(-10.7%) |
| Sep 2021 | - | -$161.35 M(-7.1%) | -$517.45 M(+31.1%) |
| Jun 2021 | - | -$173.65 M(+36.4%) | -$394.56 M(+76.0%) |
| Mar 2021 | - | -$127.32 M(+130.9%) | -$224.23 M(+87.9%) |
| Dec 2020 | -$110.86 M(+8.2%) | -$55.14 M(+43.4%) | -$119.36 M(+13.0%) |
| Sep 2020 | - | -$38.46 M(+1059.3%) | -$105.61 M(+21.6%) |
| Jun 2020 | - | -$3.32 M(-85.2%) | -$86.86 M(+4.0%) |
| Mar 2020 | - | -$22.45 M(-45.7%) | -$83.54 M(+0.3%) |
| Dec 2019 | -$102.44 M(+29.3%) | -$41.38 M(+110.0%) | -$83.26 M(+98.8%) |
| Sep 2019 | - | -$19.71 M(-11.1%) | -$41.87 M(+88.9%) |
| Mar 2019 | - | -$22.17 M | -$22.17 M |
| Dec 2018 | -$79.20 M | - | - |
FAQ
- What is CureVac NV annual EBITDA?
- What is the all time high annual EBITDA for CureVac NV?
- What is CureVac NV annual EBITDA year-on-year change?
- What is CureVac NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for CureVac NV?
- What is CureVac NV quarterly EBITDA year-on-year change?
- What is CureVac NV TTM EBITDA?
- What is the all time high TTM EBITDA for CureVac NV?
- What is CureVac NV TTM EBITDA year-on-year change?
What is CureVac NV annual EBITDA?
The current annual EBITDA of CVAC is -$253.43 M
What is the all time high annual EBITDA for CureVac NV?
CureVac NV all-time high annual EBITDA is -$79.20 M
What is CureVac NV annual EBITDA year-on-year change?
Over the past year, CVAC annual EBITDA has changed by -$19.62 M (-8.39%)
What is CureVac NV quarterly EBITDA?
The current quarterly EBITDA of CVAC is $412.68 M
What is the all time high quarterly EBITDA for CureVac NV?
CureVac NV all-time high quarterly EBITDA is $412.68 M
What is CureVac NV quarterly EBITDA year-on-year change?
Over the past year, CVAC quarterly EBITDA has changed by $0.00 (0.00%)
What is CureVac NV TTM EBITDA?
The current TTM EBITDA of CVAC is $186.66 M
What is the all time high TTM EBITDA for CureVac NV?
CureVac NV all-time high TTM EBITDA is $186.66 M
What is CureVac NV TTM EBITDA year-on-year change?
Over the past year, CVAC TTM EBITDA has changed by $0.00 (0.00%)